Desq Long
Sign in

Company

Elevance Health, Inc.

ELV · CIK 0001156039

USASPENDING
$6,408,390.00

WELLPOINT FEDERAL SOLUTIONS, INC.

Awarded a contract by Department of Health and Human Services.

Awarding Agency Department of Health and Human Services · Awarding Sub-Agency Centers for Medicare and Medicaid Services · Award ID 75FCMC22C0003 · Modification P00061 · Parent (listed) ELV · PSC G007

Awarded Aug 11, 2026 · First seen Nov 21, 2026

Source: USAspending.gov · 75FCMC22C0003-P00061 · View filing →

USASPENDING
$1,425,747.00

WELLPOINT FEDERAL SOLUTIONS, INC.

Awarded a contract by Department of Health and Human Services.

Awarding Agency Department of Health and Human Services · Awarding Sub-Agency Centers for Medicare and Medicaid Services · Award ID 75FCMC25FJ091 · Modification P00002 · Parent (listed) ELV · PSC R499

Awarded Aug 7, 2026 · First seen Nov 21, 2026

Source: USAspending.gov · 75FCMC25FJ091-P00002 · View filing →

SEC FORM 4
$173,600.00

Elevance Health, Inc. (ELV)

Sale of 400 shares at $434 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$195,276.40

Elevance Health, Inc. (ELV)

Sale of 440 shares at $443.81 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$71,176.00

Elevance Health, Inc. (ELV)

Sale of 160 shares at $444.85 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$368,883.35

Elevance Health, Inc. (ELV)

Sale of 827 shares at $446.05 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$122,082.87

Elevance Health, Inc. (ELV)

Sale of 273 shares at $447.19 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$139,715.25

Elevance Health, Inc. (ELV)

Sale of 321 shares at $435.25 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$724,092.00

Elevance Health, Inc. (ELV)

Sale of 1,660 shares at $436.20 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$244,759.20

Elevance Health, Inc. (ELV)

Sale of 560 shares at $437.07 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$105,172.80

Elevance Health, Inc. (ELV)

Sale of 240 shares at $438.22 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$509,530.00

Elevance Health, Inc. (ELV)

Sale of 1,160 shares at $439.25 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$757,556.80

Elevance Health, Inc. (ELV)

Sale of 1,720 shares at $440.44 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$1,034,059.62

Elevance Health, Inc. (ELV)

Sale of 2,343 shares at $441.34 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$212,452.80

Elevance Health, Inc. (ELV)

Sale of 480 shares at $442.61 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001748691-26-000008 · filed 2026-10-23 · View filing →

SEC FORM 4
$1,607,935.23

Elevance Health, Inc. (ELV)

Disposition (code F) of 4,161 shares at $386.43 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code F

Traded Oct 2, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001748691-26-000005 · filed 2026-10-06 · View filing →

SEC FORM 4
$0.00

Elevance Health, Inc. (ELV)

Acquisition (code A) of 2,627 shares at $0 per share.

Reporting Person Kaye Mark · Officer Title EVP & CFO · Transaction Code A

Traded Oct 2, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001748691-26-000005 · filed 2026-10-06 · View filing →

SEC FORM 4
$105,768.90

Elevance Health, Inc. (ELV)

Disposition (code F) of 255 shares at $414.78 per share.

Reporting Person Wessling Erin M · Officer Title EVP & Chief Legal Officer · Transaction Code F

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0002084548-26-000005 · filed 2026-09-04 · View filing →

SEC FORM 4
$58,440.96

Elevance Health, Inc. (ELV)

Disposition (code F) of 144 shares at $405.84 per share.

Reporting Person Craig Ryan R · Officer Title EVP & Chief HR Officer · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0002084547-26-000009 · filed 2026-09-04 · View filing →

SEC FORM 4
$38,148.96

Elevance Health, Inc. (ELV)

Disposition (code F) of 94 shares at $405.84 per share.

Reporting Person Wessling Erin M · Officer Title EVP & Chief Legal Officer · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0002084548-26-000005 · filed 2026-09-04 · View filing →

STOCK ACT PTR
$15,001 - $50,000

Elevance Health Inc (ELV)

Purchase.

Filer Markwayne Mullin · Chamber Senate · District OK · Owner Joint · Transaction Type Purchase · Asset Type Stock

Traded Dec 29, 2025 · Disclosed Jan 16, 2026FILED +18 DAYS

Source: Senate eFD PTR · b195126e-7bb2-4d54-baf5-e6fc8e7a0165 · filed 2026-01-16 · View filing →

STOCK ACT PTR
$15,001 - $50,000

Elevance Health, Inc. Common Stock (ELV)

Purchase.

Filer Markwayne Mullin · Chamber Senate · District OK · Owner Joint · Transaction Type Purchase · Asset Type Stock

Traded Dec 29, 2025 · Disclosed Jan 15, 2026FILED +17 DAYS

Source: Senate eFD PTR · b195126e-7bb2-4d54-baf5-e6fc8e7a0165 · filed 2026-01-15 · View filing →

STOCK ACT PTR
$1,001 - $15,000

Elevance Health Inc (ELV)

Sale.

Filer John Fetterman · Chamber Senate · District PA · Transaction Type Sale · Asset Type Corporate Bond

Traded Sep 19, 2025 · Disclosed Oct 7, 2025FILED +18 DAYS

Source: Senate eFD PTR · 638bfeba-3c29-426a-94f5-a962bf58ee8a · filed 2025-10-07 · View filing →